ArticleOncotarget2016

Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation.

Nayoung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.